Skip to content

The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of Practice

The Only Blood Culture for Diagnosis of Bacteremia - Comparative Study of Practice

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02516514
Acronym
HEMU
Enrollment
302
Registered
2015-08-06
Start date
2010-12-31
Completion date
2012-12-31
Last updated
2015-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bloodstream Infection

Keywords

Blood culture, Bacteremia, Single sampling

Brief summary

Current recommendations for the diagnosis of bacteremia based on the embodiment February-March blood cultures separated by a minimum interval of 30 minutes. Each blood culture comprises seeding a pair of aerobic and anaerobic vials inoculated each with 5 to 10 ml of blood. The sensitivity and specificity of this technique depends essentially on the amount of blood removed since there is a direct relationship between the volume of blood inoculated into each flask and the efficiency of the technique. A preliminary study conducted at the University Hospital of Caen found that 14-30% of patients depending on the services had received only one blood culture. In addition, at least four blood cultures in 24 hours were taken for 10 to 20% of patients. The practice of a single blood culture reduces the sensitivity of the analysis due to insufficient total amount of blood collected. The practice of too many blood cultures increases the risk of false positive (presence of contaminating bacteria), generates extra work for healthcare personnel (and laboratory) and represents a significant cost for an unproven benefit. The investigators propose to evaluate a single blood culture sampling technique with seeding 4 vials (2 aerobic and anaerobic 2).

Detailed description

Blood cultures will be collected from patients admitted with on of the following signs: fever (≥38.5°C), hypothermia (≤36°C), chills or shock. For the first blood culture, 40 mL of blood will be obtained aseptically by a single phlebotomy and equally distributed into two BacT/Alert FA aerobic bottles and two BacT/Alert FN anaerobic bottles (bioMérieux, La-Balme-les-Grottes, France). The four bottles will be labelled from one to four in the following order: aerobic-anaerobic-aerobic-anaerobic. Within the next 24 h, one to three other 20-mL blood cultures consisting of a single pair of aerobic and anaerobic bottles will have to be performed, spaced by a minimum of 30 minutes. Bottles will be incubated for 5 days or until positivity reported by the BacT/Alert 3D instrument.

Interventions

PROCEDURESingle-sampling strategy vs multi-sampling strategy for the diagnosis of bacteremia

Comparison between two strategies of blood culture (single-sampling strategy and multi-sampling strategy) for the diagnosis of bacteremia

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient who is at least 18 years * Patients admitted to an emergency department of a three CHU Caen, Lille, Rouen * Patient with clinical justifying the realization of blood cultures (as good practice recommendations) * Patients who received information about the study or if his legal representatives or his close entourage * Patient not objecting to the venipuncture

Exclusion criteria

* Patient who direct venipuncture is impossible * Patient refusing venipuncture * Patient aged under 18 * Patient with impaired vigilance and not accompanied by a family member or a trusted person may receive clear information protocol * Vulnerable Patient and not accompanied by a family member or a trusted person may receive clear information protocol

Design outcomes

Primary

MeasureTime frame
Rate of pathogens identified by each strategybaseline

Secondary

MeasureTime frame
Proportion of blood cultures contaminated in each strategybaseline

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026